137 related articles for article (PubMed ID: 22137928)
1. Tolerance induced by anti-DNA Ig peptide in (NZB×NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells.
Yu Y; Liu Y; Shi FD; Zou H; Hahn BH; La Cava A
Clin Immunol; 2012 Mar; 142(3):291-5. PubMed ID: 22137928
[TBL] [Abstract][Full Text] [Related]
2. Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.
Lourenço EV; Procaccini C; Ferrera F; Iikuni N; Singh RP; Filaci G; Matarese G; Shi FD; Brahn E; Hahn BH; La Cava A
J Immunol; 2009 Jun; 182(12):7415-21. PubMed ID: 19494264
[TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():718359. PubMed ID: 34867947
[TBL] [Abstract][Full Text] [Related]
4. Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():662901. PubMed ID: 34093553
[TBL] [Abstract][Full Text] [Related]
5. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.
Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH
Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861
[TBL] [Abstract][Full Text] [Related]
6. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
7. A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice.
Brosh N; Dayan M; Fridkin M; Mozes E
Immunol Lett; 2000 Apr; 72(1):61-8. PubMed ID: 10789683
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice.
Skaggs BJ; Lourenço EV; Hahn BH
Lupus; 2011 Aug; 20(9):912-20. PubMed ID: 21562020
[TBL] [Abstract][Full Text] [Related]
10. Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus mice.
Dinesh R; Hahn BH; La Cava A; Singh RP
Genes Immun; 2011 Jul; 12(5):360-9. PubMed ID: 21326316
[TBL] [Abstract][Full Text] [Related]
11. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
12. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
13. T-cell tolerance induction is normal in the (NZB x NZW)F1 murine model of systemic lupus erythematosus.
Wither J; Vukusic B
Immunology; 2000 Mar; 99(3):345-51. PubMed ID: 10712663
[TBL] [Abstract][Full Text] [Related]
14. Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice.
Clark AG; Fan Q; Brady GF; Mackin KM; Coffman ED; Weston ML; Foster MH
Autoimmunity; 2013 May; 46(3):188-204. PubMed ID: 23157336
[TBL] [Abstract][Full Text] [Related]
15. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.
Hahn BH; Singh RP; La Cava A; Ebling FM
J Immunol; 2005 Dec; 175(11):7728-37. PubMed ID: 16301683
[TBL] [Abstract][Full Text] [Related]
17. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
Fournel S; Muller S
Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
[TBL] [Abstract][Full Text] [Related]
18. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
Scalapino KJ; Daikh DI
PLoS One; 2009 Jun; 4(6):e6031. PubMed ID: 19551149
[TBL] [Abstract][Full Text] [Related]
19. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA.
Wellmann U; Werner A; Winkler TH
Eur J Immunol; 2001 Sep; 31(9):2800-10. PubMed ID: 11536179
[TBL] [Abstract][Full Text] [Related]
20. A peptide derived from a polyreactive monoclonal anti-DNA natural antibody can modulate lupus development in (NZBxNZW)F1 mice.
Jouanne C; Avrameas S; Payelle-Brogard B
Immunology; 1999 Mar; 96(3):333-9. PubMed ID: 10233713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
